This ATM adds a new dilutive capital source but does not address the fundamental solvency risk. Monitor for actual ADS sale volumes and pricing disclosures on Form 6-K filings. The stock trades near $0.67 — any acceleration of ATM sales could further pressure price. The Perceptive conversion overhang (potentially 8.3x current shares) and Yorkville SEPA remain the dominant bearish structural factors.
Price Chart
Executive Summary
Trinity Biotech filed a 424B5 prospectus supplement to establish a new at-the-market (ATM) offering facility with Lucid Capital Markets for up to $4.35 million of ADSs. The filing comes just days after terminating a prior ATM with Craig-Hallum, highlighting the company's urgent need for working capital to support operations amid a deeply negative equity position (-$72M shareholders' equity as of Dec 31, 2025), heavy debt load ($132M total debt pro forma), and ongoing Nasdaq MVPHS delisting risk. The up-to-32% dilution from the max offering compounds the already massive potential dilution from existing convertible obligations and the Yorkville SEPA.
Key Facts
- New ATM facility with Lucid Capital Markets for up to $4,352,314 in aggregate offering price of ADSs
- 3.0% commission to Lucid on gross proceeds; Lucid indemnified for securities law liabilities
- 635,571 new ADSs represent up to ~32% dilution vs. 20,250,869 ADSs outstanding pre-offering
- Shareholders' equity was negative $(71,982,000) as of Dec 31, 2025; accumulated deficit of $(116,169,000)
- Pro forma total debt of $132,121,000 including $115,581,000 Senior Secured Term Loan
- Up to 3.36 billion additional Ordinary Shares potentially issuable to Perceptive at minimum conversion price of $0.5061 per ADS
- Yorkville SEPA allows sale of up to $25M of ADSs at 95-97% of VWAP, adding further overhang
- Prior ATM with Craig-Hallum was terminated June 2, 2026 (had been inactive since March 2025)
- Proceeds to be used for general corporate purposes and working capital
- Cash and cash equivalents were only $5,138,000 actual / $7,638,000 pro forma as of Dec 31, 2025
Financial Impact
Up to $4.35M gross proceeds with net ~$4.22M after 3% commission; potential dilution of up to 32% of current ADS float at assumed price of $0.6642/ADS
Risk Factors
- Immediate and substantial dilution to existing shareholders upon any ATM sales
- Massive overhang from Perceptive conversion obligations (up to 3.36B shares) and Yorkville SEPA ($25M)
- Negative shareholders' equity and high debt load raise going-concern risk
- Nasdaq delisting risk from MVPHS non-compliance remains unresolved
- Cash position of only $5.1-7.6M against $132M debt suggests severe liquidity constraints
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001554855-26-001320 |
| Document: 0001554855-26-001320-index-headers.html | 0001554855-26-001320 |
| Document: 0001554855-26-001320-index.html | 0001554855-26-001320 |
| Document: 0001554855-26-001320.txt | 0001554855-26-001320 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 21d ago | 6-K | $5.77 | awaiting T+60 | — | $7.11 (+23.22%) |
Sep 9, 2026 6w ago | 6-K | $8.00 | awaiting T+60 | — | $7.11 (−11.12%) |
Sep 2, 2026 7w ago | EFFECT | $9.60 | awaiting T+60 | — | $7.11 (−25.94%) |
Aug 28, 2026 8w ago | 6-K | $9.87 | awaiting T+60 | — | $7.11 (+27.96%) |
Aug 21, 2026 9w ago | F-1/A | $10.60 | awaiting T+60 | — | $7.11 (−32.92%) |
Aug 17, 2026 10w ago | 6-K | $11.17 | awaiting T+60 | — | $7.11 (−36.35%) |
Aug 14, 2026 10w ago | 6-K | $11.67 | awaiting T+60 | — | $7.11 (−39.07%) |
Jul 22, 2026 13w ago | 6-K | $0.3033 $0.2643 | ▼ −12.85% | ▼ −16.11% | $7.11 (+2244.21%) |
Jul 22, 2026 13w ago | 6-K | $0.3033 $0.2643 | ▼ −12.85% | ▼ −16.11% | $7.11 (+2244.21%) |
Jul 2, 2026 16w ago | 6-K | $0.3765 $0.2240 | ▼ −40.50% | ▼ −43.30% | $7.11 (+1788.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers